Mark Goodfield
- Dermatology top 0.5%
- Dermatology and Skin Diseases 13
- Dermatologic Treatments and Research 8
- Rheumatology top 1%
- Systemic Lupus Erythematosus Research 23
- Immunology and Allergy top 2%
- Immunology top 5%
- Psoriasis: Treatment and Pathogenesis 15
- T-cell and B-cell Immunology 9
- Atherosclerosis and Cardiovascular Diseases 6
- Internal Medicine top 5%
-
- Systemic Sclerosis and Related Diseases 13
- Autoimmune Bullous Skin Diseases 8
- Co-authors
- Alison LaytonW.J. CunliffeE. G. V. EvansPaul EmeryN.R. RowellKaren BowdenSally H. IbbotsonJ A Davies
- Journals
- British Journal of Dermatology (16 papers)Clinical and Experimental Dermatology (9 papers)Annals of the Rheumatic Diseases (6 papers)
- Partner nations
- United KingdomCanadaUnited States
In The Last Decade
Mark Goodfield
80 papers receiving 2.0k citations
Peers
Comparison fields: 5 of 110
- Dermatology 863
- Rheumatology 725
- Immunology and Allergy 274
- Immunology 768
- Internal Medicine 84
Countries citing papers authored by Mark Goodfield
This map shows the geographic impact of Mark Goodfield's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Goodfield with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Goodfield more than expected).
Fields of papers citing papers by Mark Goodfield
This network shows the impact of papers produced by Mark Goodfield. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Goodfield. The network helps show where Mark Goodfield may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mark Goodfield, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 2 | |
| 2 | Effects of apremilast on pruritus in patients with moderate to severe plaque psoriasis : results from the ESTEEM 1 and 2 trials | 2015 | 1 |
| 3 | 2012 | 69 | |
| 4 | 2011 | 66 | |
| 5 | 2011 | 119 | |
| 6 | 2011 | 17 | |
| 7 | 2009 | 3 | |
| 8 | 2009 | 41 | |
| 9 | 2004 | 9 | |
| 10 | 2004 | 7 | |
| 11 | 2000 | 20 | |
| 12 | 1997 | 7 | |
| 13 | 1995 | 19 | |
| 14 | 1995 | 35 | |
| 15 | 1994 | 11 | |
| 16 | 1994 | 76 | |
| 17 | 1994 | 4 | |
| 18 | 1990 | 19 | |
| 19 | 1989 | 52 | |
| 20 | 1988 | 12 |
About Mark Goodfield
Mark Goodfield is a scholar working on Dermatology, Rheumatology and Immunology, having authored 81 papers that have together received 2.1k indexed citations. Recurring topics across this work include Systemic Lupus Erythematosus Research (23 papers), Psoriasis: Treatment and Pathogenesis (15 papers), Dermatology and Skin Diseases (13 papers), Systemic Sclerosis and Related Diseases (13 papers), T-cell and B-cell Immunology (9 papers), Autoimmune Bullous Skin Diseases (8 papers), Dermatologic Treatments and Research (8 papers) and Atherosclerosis and Cardiovascular Diseases (6 papers). The work is most often cited by research in Dermatology (863 citations), Rheumatology (725 citations) and Immunology and Allergy (274 citations). Mark Goodfield has collaborated with scholars based in United Kingdom, Canada and United States. Frequent co-authors include Alison Layton, W.J. Cunliffe, E. G. V. Evans, Paul Emery, N.R. Rowell, Karen Bowden, Sally H. Ibbotson, J A Davies, Katy Davison and Edward J. Wood. Their work appears in journals such as British Journal of Dermatology, Clinical and Experimental Dermatology, Annals of the Rheumatic Diseases, Journal of Investigative Dermatology and Lara D. Veeken.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.